3-37048583-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000249.4(MLH1):​c.1963A>G​(p.Ile655Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000727 in 1,613,630 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I655T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00051 ( 3 hom. )

Consequence

MLH1
NM_000249.4 missense

Scores

3
15

Clinical Significance

Likely benign reviewed by expert panel U:1B:29O:1

Conservation

PhyloP100: 1.92

Publications

25 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 18 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 30 uncertain in NM_000249.4
BP4
Computational evidence support a benign effect (MetaRNN=0.013260722).
BP6
Variant 3-37048583-A-G is Benign according to our data. Variant chr3-37048583-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 41637.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00282 (429/152048) while in subpopulation AFR AF = 0.00863 (358/41476). AF 95% confidence interval is 0.00789. There are 1 homozygotes in GnomAd4. There are 203 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.1963A>Gp.Ile655Val
missense
Exon 17 of 19NP_000240.1P40692-1
MLH1
NM_001354629.2
c.1864A>Gp.Ile622Val
missense
Exon 16 of 18NP_001341558.1A0AAQ5BGZ2
MLH1
NM_001354630.2
c.1798A>Gp.Ile600Val
missense
Exon 16 of 18NP_001341559.1A0A669KAW3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.1963A>Gp.Ile655Val
missense
Exon 17 of 19ENSP00000231790.3P40692-1
MLH1
ENST00000458205.6
TSL:1
c.1240A>Gp.Ile414Val
missense
Exon 18 of 20ENSP00000402667.2P40692-2
MLH1
ENST00000456676.7
TSL:1
c.1896+900A>G
intron
N/AENSP00000416687.3H0Y818

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
429
AN:
151930
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00866
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000984
Gnomad ASJ
AF:
0.0112
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00105
AC:
264
AN:
251262
AF XY:
0.000825
show subpopulations
Gnomad AFR exome
AF:
0.00935
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.00734
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000509
AC:
744
AN:
1461582
Hom.:
3
Cov.:
31
AF XY:
0.000465
AC XY:
338
AN XY:
727100
show subpopulations
African (AFR)
AF:
0.00971
AC:
325
AN:
33468
American (AMR)
AF:
0.000693
AC:
31
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00750
AC:
196
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53394
Middle Eastern (MID)
AF:
0.00260
AC:
15
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000738
AC:
82
AN:
1111758
Other (OTH)
AF:
0.00149
AC:
90
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
429
AN:
152048
Hom.:
1
Cov.:
31
AF XY:
0.00273
AC XY:
203
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.00863
AC:
358
AN:
41476
American (AMR)
AF:
0.000983
AC:
15
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
39
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000177
AC:
12
AN:
67982
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
2
Bravo
AF:
0.00309
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00931
AC:
41
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00105
AC:
127
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (8)
-
-
6
Colorectal cancer, hereditary nonpolyposis, type 2 (6)
-
-
6
Hereditary cancer-predisposing syndrome (6)
-
1
4
not provided (5)
-
-
2
Lynch syndrome (2)
-
-
1
Endometrial carcinoma (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Muir-Torré syndrome (1)
-
-
1
Muir-Torré syndrome;C1333991:Colorectal cancer, hereditary nonpolyposis, type 2;C5399763:Mismatch repair cancer syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Uncertain
0.50
D
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.63
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.41
N
PhyloP100
1.9
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.17
N
REVEL
Uncertain
0.35
Sift
Benign
0.74
T
Sift4G
Benign
0.46
T
Polyphen
0.0
B
Vest4
0.82
MVP
0.90
MPC
0.058
ClinPred
0.0024
T
GERP RS
0.59
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.047
gMVP
0.27
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55907433; hg19: chr3-37090074; API